Cavadexa 600/300 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: abacavir + lamivudine
Brand name
(ARTG)
: CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
CAVADEXA 600/300 tablets are a combinaton of two nucleoside analogues (abacavir and lamivudine). CAVADEXA 600/300 is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infection in adults and adolescents from 12 years of age.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet
- Oral
- Orange modified capsule shaped, biconvex film-coated tablets debossed with 'H' on one side and 'A1' on other side.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Store in Original Container
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 30's pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient abacavir + lamivudine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
